KRT80 and cancer: Here, we found that KRT80 mRNA expression was negatively correlated with a long overall survival time of the cancer patients with stage 2, low mutation burden, decreased mesenchymal stem and natural killer cells, but the converse results were seen in those patients with stage 3 and high mutation burden.